IPO
Hong Kong biotech Prenetics tumbles after Nasdaq debut
CEO warns key COVID-19 testing business to drop as pandemic recedes
Philippine venture 'first step,' executive says, with Middle East on the horizon
Virus test provider helped soccer's Premier League resume play
Japanese printer maker targets capacity equivalent to 100m COVID shots by 2025
Scandal-hit Japan drugmaker opts for alternative dispute model
They join global peers in pulling back as logistics, payment systems deteriorate
Global supplies shortage and dependence on West spell urgency, opportunity
Aduhelm was expected to be the company's next blockbuster but has faced doubts
Big names, startups race for ways to offer comfort, data and right mindset
Smartphone app guides users through stroke recovery with help from AI
Drugmaker ushers in 'the future' with modular production and AI
Japanese drugmaker also says vaccine proven effective in trials
Would mark country's biggest deal so far this year
Jab, different from Pfizer and Moderna's mRNA vaccines, provides 'diversity'
Reports shed light on how cartels rely on supplies from across Asia
Quick approval sought despite Medicare's decision to limit coverage
Western powers aim to reverse the industry's West-to-East shift
Former U.S. EXIM Bank chief and veteran biotech exec nominated for seats
Aging population sparks need for services but cost pressures limit profitability
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.